510(k) clearance for SenoRx's breast biopsy ultrasound system:
This article was originally published in Clinica
Executive Summary
SenoRx has received 510(k) clearance from the US FDA for its SenoSonix system, an adjunct to its EnCor breast biopsy device. The SenoSonix incorporates Aliso Viejo, California-based SenoRx's proprietary EnCor vacuum-assisted biopsy technologies with an ultrasound system developed by Ultrasonix Medical Corporation of Richmond, Canada. The product is scheduled to be launched in the US in January 2008, and SenoRx expects to receive the right to CE mark the device in the EU "in the near-term."
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.